• 2-905: Neonatal Abstinence Syndrome Literature Review

    Neonatal Abstinence Syndrome Literature Review

    Report, 2020


    Neonatal abstinence syndrome (NAS) is a condition whereby some infants exposed to particular substances in utero experience a variety of postnatal withdrawal symptoms shortly after birth. Increased rates of NAS have been reported in Canada over the past decade. This review provides information about the development and effects of NAS, modes of assessment, treatment options (both pharmacological and non-pharmacological), care guidelines for parents and caregivers, and primary prevention strategies.

    Report, 2020


    Neonatal abstinence syndrome (NAS) is a condition whereby some infants exposed to particular substances in utero experience a variety of postnatal withdrawal symptoms shortly after birth. Increased rates of NAS have been reported in Canada over the past decade. This review provides information about the development and effects of NAS, modes of assessment, treatment options (both pharmacological and non-pharmacological), care guidelines for parents and caregivers, and primary prevention strategies.



    SKU: 2-905
  • 2-906: Neonatal Abstinence Syndrome

    Neonatal Abstinence Syndrome

    Fact Sheet, 2020


    Neonatal abstinence syndrome (NAS) is a condition whereby infants who are exposed to particular substances in the womb experience a variety of withdrawal symptoms shortly after they are born. This fact sheet shares information about the signs and symptoms of NAS, treatment, at-home care recommendations, and potential long-term outcomes.

    Fact Sheet, 2020


    Neonatal abstinence syndrome (NAS) is a condition whereby infants who are exposed to particular substances in the womb experience a variety of withdrawal symptoms shortly after they are born. This fact sheet shares information about the signs and symptoms of NAS, treatment, at-home care recommendations, and potential long-term outcomes.



    SKU: 2-906